CATALOGO DEI PRODOTTI DELLA RICERCA

CALABRESE, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.114
EU - Europa 7.250
AS - Asia 5.468
SA - Sud America 870
Continente sconosciuto - Info sul continente non disponibili 307
AF - Africa 239
OC - Oceania 24
Totale 23.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.701
RU - Federazione Russa 3.164
SG - Singapore 2.145
CN - Cina 1.371
IT - Italia 1.166
GB - Regno Unito 759
BR - Brasile 686
VN - Vietnam 541
HK - Hong Kong 456
DE - Germania 413
FR - Francia 338
SE - Svezia 333
FI - Finlandia 296
IE - Irlanda 265
CA - Canada 202
KR - Corea 175
BD - Bangladesh 151
TR - Turchia 142
IN - India 96
ID - Indonesia 85
NL - Olanda 80
UA - Ucraina 78
AR - Argentina 68
JP - Giappone 68
MX - Messico 62
PL - Polonia 61
ES - Italia 60
AT - Austria 57
ZA - Sudafrica 47
TG - Togo 35
IQ - Iraq 33
BJ - Benin 32
NG - Nigeria 32
CO - Colombia 28
LT - Lituania 26
CR - Costa Rica 25
EC - Ecuador 25
BE - Belgio 24
GT - Guatemala 24
PH - Filippine 23
UZ - Uzbekistan 22
MA - Marocco 21
AU - Australia 18
CL - Cile 17
AE - Emirati Arabi Uniti 16
JM - Giamaica 16
SA - Arabia Saudita 16
SV - El Salvador 16
CH - Svizzera 15
EG - Egitto 15
HN - Honduras 14
PK - Pakistan 14
PY - Paraguay 14
AZ - Azerbaigian 12
IL - Israele 12
MY - Malesia 12
CW - ???statistics.table.value.countryCode.CW??? 11
HR - Croazia 11
MK - Macedonia 11
DZ - Algeria 10
JO - Giordania 10
NI - Nicaragua 10
VE - Venezuela 10
AL - Albania 9
CZ - Repubblica Ceca 9
GR - Grecia 9
KE - Kenya 9
RS - Serbia 9
TT - Trinidad e Tobago 9
RO - Romania 8
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
PE - Perù 7
PR - Porto Rico 7
PT - Portogallo 7
TN - Tunisia 7
GP - Guadalupe 6
OM - Oman 6
QA - Qatar 6
UY - Uruguay 6
BO - Bolivia 5
CY - Cipro 5
DK - Danimarca 5
SN - Senegal 5
AM - Armenia 4
BG - Bulgaria 4
BS - Bahamas 4
BY - Bielorussia 4
CG - Congo 4
ET - Etiopia 4
GY - Guiana 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
NO - Norvegia 4
NP - Nepal 4
SC - Seychelles 4
TH - Thailandia 4
TW - Taiwan 4
BH - Bahrain 3
Totale 22.907
Salva come PNG Salva come JPEG
Città #
Ashburn 1.431
Moscow 1.108
Singapore 1.052
San Jose 990
Dallas 728
Chandler 682
Southend 490
Hong Kong 445
Verona 403
Council Bluffs 312
Beijing 280
Dublin 258
The Dalles 241
Los Angeles 195
Munich 186
New York 186
Jacksonville 170
Ho Chi Minh City 166
Helsinki 160
Woodbridge 153
Ann Arbor 133
Houston 106
Hanoi 102
São Paulo 102
Istanbul 101
Princeton 101
Santa Clara 100
Redmond 99
Lawrence 93
Milan 91
Wilmington 81
Buffalo 78
Jinan 71
Redondo Beach 68
London 67
Montreal 66
Jakarta 63
Atlanta 55
Orem 53
Tokyo 53
Warsaw 53
Dong Ket 52
Lappeenranta 48
Nanjing 48
Lancaster 45
Rome 45
Tianjin 45
Seattle 44
Shenyang 44
Sindelfingen 44
Columbus 43
Phoenix 42
Turku 41
Chicago 39
Hebei 39
Brooklyn 38
Chennai 36
Denver 36
Johannesburg 36
Washington 36
Lomé 35
Nuremberg 34
Amsterdam 32
Cotonou 32
Redwood City 32
Seoul 31
Abuja 29
McKinney 29
Toronto 29
Guangzhou 28
Vienna 28
Carrboro 27
Changsha 27
Frankfurt am Main 27
Mexico City 27
Zhengzhou 26
Haikou 25
Paris 25
Stockholm 25
Boardman 24
Ningbo 24
San Francisco 24
Cleveland 22
Haiphong 22
Rio de Janeiro 22
Taizhou 22
Brussels 21
Da Nang 21
Bologna 20
Guatemala City 20
Naples 20
Poplar 20
Boston 19
Manchester 19
Nanchang 19
Norwalk 19
Des Moines 18
Tashkent 18
Falkenstein 17
Hangzhou 17
Totale 13.149
Salva come PNG Salva come JPEG
Nome #
Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis 407
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 324
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 279
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 251
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 240
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 231
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 231
Can DTI and 3D-SHORE based indices differentiate RRMS from PMS Patients? 230
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 228
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 225
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 224
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 223
Coping strategies and their impact on quality of life and physical disability of people with multiple sclerosis 221
A case of acute fulminant multiple sclerosis treated with alemtuzumab 220
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 209
A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia 207
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 198
Explainable 3D-CNN for multiple sclerosis patients stratication 197
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 196
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 195
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 194
Assessing response to interferon-β in a multicenter dataset of patients with MS 190
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results 190
Epilepsy in multiple sclerosis: The role of temporal lobe damage 189
Response to Nagai et al. 186
A videogame-based approach to measuring information processing speed in multiple sclerosis patients 184
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes 183
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 182
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 179
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 178
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 178
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 177
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 177
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 176
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 175
The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis 175
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 174
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 174
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 173
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 173
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 172
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 171
Interpretable Deep Learning as a means for decrypting disease signature in Multiple Sclerosis 171
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 170
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients 170
Lost in classification: lower cognitive functioning in apparently cognitive normal newly diagnosed RRMS patients 169
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 168
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 166
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 165
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 165
Visual-attentional load unveils slowed processing speed in multiple sclerosis patients: a pilot study with a tablet-based videogame 164
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 163
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 162
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 161
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 159
Classification of upper limb spasticity patterns in patients with multiple sclerosis: a pilot observational study 158
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 158
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 157
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 156
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 155
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 155
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 155
Correlating Dti and 3d-Shore Based Indices with Neurological Disability Scores of Multiple Sclerosis Patients 155
"What is hidden behind the mask?" Facial emotion recognition at the time of COVID-19 pandemic in cognitively normal multiple sclerosis patients 155
Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical multiple sclerosis lesion detection 154
False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm 154
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 154
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 154
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 153
Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation 153
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients 151
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 149
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 148
Impact of model selection procedure on Deep Neural Networks ensemble for the Choroid Plexus segmentation in Multiple Sclerosis 148
Exploring the origins of grey matter damage in multiple sclerosis. 147
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 146
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 144
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis 143
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 143
ASCHOPLEX: A generalizable approach for the automatic segmentation of choroid plexus 143
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 142
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 141
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 140
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 139
Heterogeneity of cortical lesions in multiple sclerosis: An MRI perfusion study 137
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 137
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 137
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 136
Explainable deep learning for decrypting disease signatures in multiple sclerosis 134
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 133
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 132
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 131
Choroid plexus volume in multiple sclerosis can be estimated on structural MRI avoiding contrast injection 131
Multiple sclerosis and epilepsy: much more than a coincidence 130
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 130
Multivariate data analysis suggests the link between brain microstructure and cognitive impairment in multiple sclerosis 130
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 130
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 129
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 129
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 129
Totale 17.304
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.761
article - articoli 78.746
book - libri 0
conference - conferenze 8.477
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 538
Totale 175.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022554 0 0 0 125 18 19 34 53 27 30 64 184
2022/20231.895 116 244 158 337 129 415 45 114 220 22 53 42
2023/20241.235 38 88 105 132 124 238 102 77 17 94 154 66
2024/20253.674 140 169 144 615 159 203 205 223 620 250 315 631
2025/202611.216 720 580 722 1.847 2.968 657 952 576 975 696 211 312
2026/20272.185 187 323 444 1.231 0 0 0 0 0 0 0 0
Totale 23.272